Effectiveness and Safety of Nadroparin Therapy in Preterm and Term Neonates with Venous Thromboembolism.

Jeanine SolMarit BoermaIrene L M Klaassen Sinno H P SimonsBregje WitjesEnno WildschutIrwin ReissCornelia Heleen van Ommen

Published in: Journal of clinical medicine (2021)

High nadroparin dosages are needed to reach TTR in neonates, which seem to be safe. Clot resolution may occur without reaching TTR. Subcutaneous catheters may cause important bleeding complications.

Keyphrases

low birth weight
preterm infants
venous thromboembolism
gestational age
preterm birth
direct oral anticoagulants
atrial fibrillation
risk factors
single molecule
stem cells
mesenchymal stem cells
bone marrow
smoking cessation